Given the broader relevance of PI3K activation across multiple cancer types, KRIT1 may represent a context-specific biomarker or therapeutic target in a wide range of malignancies where glycation and redox imbalance converge to drive tumor progression. Here, KRIT1 is linked to neoplasm.